SLU-PP-332 10mg
10mgAn ERR-alpha agonist studied for its potential to mimic the metabolic improvements associated with exercise.
Overview
SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptor alpha (ERR-alpha), a transcription factor central to energy metabolism and mitochondrial function.
This product is supplied as 10mg of lyophilised powder for laboratory reconstitution and research use only.
Mechanism of action
By activating ERR-alpha, SLU-PP-332 upregulates genes involved in mitochondrial biogenesis and oxidative metabolism, promoting a shift toward fatty-acid oxidation in research models.
This transcriptional programme resembles the adaptations produced by endurance exercise, which is why it is described as an exercise mimetic.
Research highlights
SLU-PP-332 has generated research interest as one of the first compounds shown to activate the exercise-associated ERR pathway pharmacologically.
Animal studies report increased energy expenditure and improved metabolic markers, making it a notable reference compound in metabolic research.
Reference dosing
Typical research protocols involve daily dosing. This reflects published research protocols only and is not a recommendation for human use.
Storage & handling
Store lyophilised vials refrigerated at 2-8C, protected from light. Keep reconstituted solution refrigerated and use per protocol.
Specifications
| Contents | SLU-PP-332 10mg |
| Form | Lyophilised powder |
| Presentation | Single vial |
| Purity | >=99% (HPLC) |
| Reconstitution | Bacteriostatic water (not included) |
Frequently asked questions
What is SLU-PP-332?
It is an ERR-alpha agonist studied as an exercise mimetic for its effects on mitochondrial function and energy metabolism.
How does it act as an exercise mimetic?
It activates the ERR transcriptional pathway that endurance exercise engages, promoting mitochondrial biogenesis and fat oxidation in research models.